Pulsatile MAPK Signaling Modulates p53 Activity to Control Cell Fate Decisions at the G2 Checkpoint for DNA Damage. (2020)
Attributed to:
Therapeutic target discovery and validation programme & the systems microscopy initiative
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.celrep.2020.01.074
PubMed Identifier: 32075732
Publication URI: http://europepmc.org/abstract/MED/32075732
Type: Journal Article/Review
Volume: 30
Parent Publication: Cell reports
Issue: 7